M. D. Chaplin

1.3k total citations
36 papers, 1.1k citations indexed

About

M. D. Chaplin is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, M. D. Chaplin has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 10 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in M. D. Chaplin's work include Inflammatory mediators and NSAID effects (9 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Analytical Chemistry and Chromatography (3 papers). M. D. Chaplin is often cited by papers focused on Inflammatory mediators and NSAID effects (9 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Analytical Chemistry and Chromatography (3 papers). M. D. Chaplin collaborates with scholars based in United States, Poland and Canada. M. D. Chaplin's co-authors include Eugene J. Segre, Richard Runkel, Enrico Forchielli, Gilbert J. Mannering, Hilli Sevelius, Gerhard Boost, C. Nerenberg, Rebecca L. Chan, Nancy Chu and William C. Cooper and has published in prestigious journals such as Clinical Infectious Diseases, Analytical Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

M. D. Chaplin

35 papers receiving 918 citations

Peers

Countries citing papers authored by M. D. Chaplin

Since Specialization

Citations

This map shows the geographic impact of M. D. Chaplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. D. Chaplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. D. Chaplin more than expected).

Fields of papers citing papers by M. D. Chaplin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. D. Chaplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. D. Chaplin. The network helps show where M. D. Chaplin may publish in the future.

Co-authorship network of co-authors of M. D. Chaplin

This figure shows the co-authorship network connecting the top 25 collaborators of M. D. Chaplin. A scholar is included among the top collaborators of M. D. Chaplin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. D. Chaplin. M. D. Chaplin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chiral Kinetics and Dynamics of Ketorolac 1996 ·The Journal of Clinical Pharmacology ·Edward J. Mroszczak, Daniel L. Combs, M. D. Chaplin, (unknown), Thomas Tarnowski, (unknown), (unknown), Aileen E. Boyd, J.M. Young, LINVAL R. DEPASS	44
2	Bioavailability of nafarelin in healthy volunteers 1992 ·American Journal of Obstetrics and Gynecology ·M. D. Chaplin	14
3	Clinical Pharmacokinetics of Ganciclovir in Patients with Normal and Impaired Renal Function 1988 ·Clinical Infectious Diseases ·Jean‐Pierre Sommadossi, (unknown), (unknown), (unknown), (unknown), M. D. Chaplin, C. Nerenberg, Stuart H. Koretz, William Buhles	87
4	Absorption and metabolism of nafarelin, a potent agonist of gonadotropin-releasing hormone 1988 ·Clinical Pharmacology & Therapeutics ·Rebecca L. Chan, Milan R. Henzl, (unknown), (unknown), C. Nerenberg, Shabbir T. Anik, M. D. Chaplin	33
5	Disposition of nafimidone in rats. 1987 ·Drug Metabolism and Disposition ·(unknown), (unknown), Stephanie A. Smith, (unknown), M. D. Chaplin, David J. Hall	6
6	Inhibition and induction of hepatic drug metabolism in rats and mice by nafimidone and its major metabolite nafimidone alcohol. 1987 ·Drug Metabolism and Disposition ·(unknown), Stephanie A. Smith, (unknown), (unknown), M. D. Chaplin	7
7	Identification of major urinary metabolites of nafarelin acetate, a potent agonist of luteinizing hormone-releasing hormone, in the rhesus monkey. 1985 ·Drug Metabolism and Disposition ·Rebecca L. Chan, M. D. Chaplin	6
8	Disposition of nafarelin acetate, a potent agonist of luteinizing hormone-releasing hormone, in rats and rhesus monkeys. 1985 ·Drug Metabolism and Disposition ·Nancy Chu, Rebecca L. Chan, (unknown), M. D. Chaplin	16
9	In vitro studies on the binding of cloprednol to human plasma proteins 1982 ·Journal of Steroid Biochemistry ·R. V. Tomlinson, Richard Runkel, M. D. Chaplin, Larry E. Bowen, (unknown), Nancy Chu	7
10	Isolation and identification of an oxidatively defluorinated metabolite of flunisolide in man. 1981 ·Drug Metabolism and Disposition ·L Tökès, (unknown), Michael L. Maddox, M. D. Chaplin, Nancy Chu	0
11	Mechanism for the oxidative defluorination of flunisolide. 1981 ·Journal of Pharmacology and Experimental Therapeutics ·Philip Teitelbaum, Nancy Chu, (unknown), L Tökès, (unknown), (unknown), M. D. Chaplin	12
12	Correlation of flunisolide plasma levels to eosinopenic response in humans 1980 ·Journal of Allergy and Clinical Immunology ·M. D. Chaplin, William C. Cooper, Eugene J. Segre, Joseph Oren, Richard E. Jones, C. Nerenberg	31
13	Sex-dependent differences in drug metabolism in the rat. IV. Effect of morphine administration. 1974 ·PubMed ·Norman E. Sládek, M. D. Chaplin, Gilbert J. Mannering	34
14	Nonlinear plasma level response to high doses of naproxen 1974 ·Clinical Pharmacology & Therapeutics ·Richard Runkel, Enrico Forchielli, Hilli Sevelius, M. D. Chaplin, Eugene J. Segre	107
15	SEX-DEPENDENT DIFFERENCES IN DRUG METABOLISM IN THE RAT 1974 ·Drug Metabolism and Disposition ·Norman E. Sládek, M. D. Chaplin, Gilbert J. Mannering	2
16	Naproxen-Metabolism, Excretion and Comparative Pharmacokinetics 1973 ·Scandinavian Journal of Rheumatology ·Richard Runkel, Enrico Forchielli, Gerhard Boost, M. D. Chaplin, Robert E. Hill, Hilli Sevelius, (unknown), Eugene J. Segre	42
17	Displacement of Thiopental from Plasma Proteins by Nonsteroidal Anti-inflammatory Agents 1973 ·Experimental Biology and Medicine ·M. D. Chaplin, Adolph P. Roszkowski, R. K. Richards	19
18	Role of Phospholipids in the Hepatic Microsomal Drug-Metabolizing System 1970 ·Molecular Pharmacology ·M. D. Chaplin, Gilbert J. Mannering	72
19	Induction of Drug Metabolism 1969 ·Molecular Pharmacology ·Don W. Shoeman, M. D. Chaplin, Gilbert J. Mannering	6
20	Amino Alcohols and Methyl Donors in Rats Fed Low Choline Diets Containing Added Cholesterol 1966 ·Journal of Nutrition ·M. D. Chaplin, Dwight J. Mulford	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact